A comparative study of the sarcopenia screening in older patients with interstitial lung disease.
Frailty
Interstitial lung diseases
Physical performance
Sarcopenia
Journal
BMC pulmonary medicine
ISSN: 1471-2466
Titre abrégé: BMC Pulm Med
Pays: England
ID NLM: 100968563
Informations de publication
Date de publication:
25 Jan 2022
25 Jan 2022
Historique:
received:
25
09
2021
accepted:
24
01
2022
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
15
3
2022
Statut:
epublish
Résumé
The Asian Working Group for Sarcopenia 2019 (AWGS 2019) is the gold standard diagnostic criteria for sarcopenia in Asian populations. The calf circumference (CalF), the strength, assistance in walking, rising from a chair, climbing stairs, and falls (SARC-F) and the SARC-CalF questionnaires for sarcopenia screening have been used by AWGS 2019. The aim of this study was to assess accuracy of these three sarcopenia screening tools in patients with interstitial lung disease. In this cross-sectional study, stable patients with interstitial lung disease were enrolled. The SARC-F, SARC-CalF, and CalF, used in patients with interstitial lung disease, were compared to the diagnostic criteria proposed by AWGS 2019. The accuracy of screening tools was compared using sensitivity and specificity. Moreover, areas under the receiver operating characteristic curves (AUC) were computed. Seventy eight patients were analyzed, and sarcopenia was identified in 25 (32.1%) patients with interstitial lung disease by the AWGS 2019 criteria. The sensitivity of the CalF was highest (96%) of the three screening tools, while the specificity was 60%. The sensitivity of SARC-F and SARC-CalF were 24% and 68%, while the specificity were 92% and 66%, respectively. The AUCs of CalF, SARC-F, and SARC-CalF in all patients were 0.78, 0.58, and 0.67, respectively. The CalF is most suitable for screening sarcopenia in patients with interstitial lung disease, while SARC-F and SARC-CalF are not.
Sections du résumé
BACKGROUND
BACKGROUND
The Asian Working Group for Sarcopenia 2019 (AWGS 2019) is the gold standard diagnostic criteria for sarcopenia in Asian populations. The calf circumference (CalF), the strength, assistance in walking, rising from a chair, climbing stairs, and falls (SARC-F) and the SARC-CalF questionnaires for sarcopenia screening have been used by AWGS 2019. The aim of this study was to assess accuracy of these three sarcopenia screening tools in patients with interstitial lung disease.
METHODS
METHODS
In this cross-sectional study, stable patients with interstitial lung disease were enrolled. The SARC-F, SARC-CalF, and CalF, used in patients with interstitial lung disease, were compared to the diagnostic criteria proposed by AWGS 2019. The accuracy of screening tools was compared using sensitivity and specificity. Moreover, areas under the receiver operating characteristic curves (AUC) were computed.
RESULTS
RESULTS
Seventy eight patients were analyzed, and sarcopenia was identified in 25 (32.1%) patients with interstitial lung disease by the AWGS 2019 criteria. The sensitivity of the CalF was highest (96%) of the three screening tools, while the specificity was 60%. The sensitivity of SARC-F and SARC-CalF were 24% and 68%, while the specificity were 92% and 66%, respectively. The AUCs of CalF, SARC-F, and SARC-CalF in all patients were 0.78, 0.58, and 0.67, respectively.
CONCLUSIONS
CONCLUSIONS
The CalF is most suitable for screening sarcopenia in patients with interstitial lung disease, while SARC-F and SARC-CalF are not.
Identifiants
pubmed: 35078452
doi: 10.1186/s12890-022-01840-3
pii: 10.1186/s12890-022-01840-3
pmc: PMC8790854
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
45Informations de copyright
© 2022. The Author(s).
Références
Eur Respir J. 2014 Dec;44(6):1428-46
pubmed: 25359355
Aging Clin Exp Res. 2017 Oct;29(5):935-942
pubmed: 27832470
J Cardiol. 2021 Dec 11;:
pubmed: 34906433
Thorax. 2012 Sep;67(9):804-10
pubmed: 22555278
Chest. 2014 Apr;145(4):723-728
pubmed: 24114524
Age Ageing. 2019 Jul 1;48(4):601
pubmed: 31081853
Lancet. 2019 Jun 29;393(10191):2636-2646
pubmed: 31171417
J Am Med Dir Assoc. 2016 Dec 1;17(12):1136-1141
pubmed: 27650212
Respir Med. 2020 Nov - Dec;174:106184
pubmed: 33086134
Ann Surg. 2014 May;259(5):960-5
pubmed: 24096757
Chest. 2017 Apr;151(4):838-844
pubmed: 27865876
Respirology. 2021 Jul;26(7):683-689
pubmed: 33876511
BMC Geriatr. 2018 Oct 19;18(1):246
pubmed: 30340462
J Am Med Dir Assoc. 2013 Aug;14(8):531-2
pubmed: 23810110
J Am Med Dir Assoc. 2018 Jan;19(1):40-45.e1
pubmed: 28843526
Arch Gerontol Geriatr. 2019 Jul - Aug;83:204-210
pubmed: 31082565
J Chronic Dis. 1987;40(6):481-9
pubmed: 3597653
J Am Med Dir Assoc. 2016 Dec 1;17(12):1142-1146
pubmed: 27815111
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2
pubmed: 32033882
J Thorac Dis. 2020 Oct;12(10):5774-5782
pubmed: 33209409
Clin Rheumatol. 2020 Jun;39(6):1757-1764
pubmed: 31938882
Cancer Med. 2020 Nov;9(21):7964-7978
pubmed: 32924316
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Cachexia Sarcopenia Muscle. 2021 Nov 23;:
pubmed: 34812591
Exp Gerontol. 2021 Feb;144:111183
pubmed: 33279661
Physiol Rev. 2019 Jan 1;99(1):427-511
pubmed: 30427277
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
J Am Med Dir Assoc. 2013 Dec;14(12):911-5
pubmed: 24094646
J Am Med Dir Assoc. 2021 Apr;22(4):746-750.e1
pubmed: 32669238
J Thorac Oncol. 2020 Jun;15(6):902-913
pubmed: 32105810
Arch Gerontol Geriatr. 2020 Mar - Apr;87:103959
pubmed: 31945638
J Am Med Dir Assoc. 2017 Feb 1;18(2):176-181
pubmed: 28043805
J Am Med Dir Assoc. 2018 Aug;19(8):685-689
pubmed: 29778639
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Ann Am Thorac Soc. 2015 Dec;12(12):S222-7
pubmed: 26653202
Asia Pac J Clin Nutr. 2019;28(1):157-165
pubmed: 30896427
Respirology. 2017 May;22(4):728-734
pubmed: 27860036
J Frailty Sarcopenia Falls. 2020 Sep 01;5(3):53-56
pubmed: 32885101